Seeing Through America’s Anti-Subsidy Measures Toward China

Published in People's Daily
(China) on 18 June 2012
by Wang Xiaofei (link to originallink to original)
Translated from by Nathan Hsu. Edited by Heather Martin.
U.S. anti-subsidy measures directed towards China have become the new focus in trade friction between China and the United States. The policies stand in violation of numerous fair trade regulations, and have damaged the trading interests of Chinese firms. On May 25, the Ministry of Commerce raised an appeal with the WTO regarding the wrongful practices used by the U.S. in anti-subsidy cases brought against China.

The unfair nature of the cases is the focal point of conflict between the two nations. The U.S. has chosen to ignore China's enormous accomplishments in decades-long reforms towards a market economy, and insisted on treating China as having a non-market economy, as well as opening anti-subsidy actions against China. Furthermore, in its anti-subsidy investigations, the U.S. has not ascertained subsidy amounts based on real subsidies provided to firms by the Chinese government, but has reapplied the "substitute country" method from its anti-dumping investigations. The method constitutes searching for a market economy outside of China to use as an external benchmark for "normal prices" within the Chinese market, then using the amount that China's domestic prices fall short of the external benchmark to determine the scope of alleged subsidies. The truth of the matter is that disparities in market price exist for products in every country, a fact which is also the basis for international trade and the theory of comparative advantage. For Chinese businesses, however, these differences are being unreasonably treated as [proof of] subsidies. The U.S. is taking anti-subsidy measures against China without a basis under international law and against precedence in U.S. law, and at the same time is using the "substitute country" method to select a high external benchmark and artificially inflate the extent of subsidization for Chinese products, resulting in a ruling unfair to Chinese businesses.

Another unfair aspect of the case, which is also a core component of China's appeal, is the issue of determining what constitutes a "public body." The U.S. is clinging to the notion that there lacks a separation between the government and businesses in China, disregarding that China's state-owned enterprises have already ended state control since implementing reforms for a market economy, and are financially and operationally independent. The United States further insists on maintaining that as long as the government owns a majority stake in a corporation, sales of the state-owned enterprise must be subsidized by the government. In many cases, the U.S. has determined state-owned enterprises to be public bodies controlled by the government despite insufficient evidence to support those claims, rulings which have been overturned by the WTO Appellate Body in the past. Despite this, the U.S. has continued on its misguided course by expanding the interpretation of "public bodies," with the result that greater numbers of Chinese exports have fallen under the scope of U.S. anti-subsidy policies, and more Chinese businesses have had their efforts to enter the U.S. market rendered practically futile.

The high levels of the duties imposed through both U.S. anti-dumping and anti-subsidy measures have also been the subject of widespread criticism, as there exist problems with double taxation. In the rulings of both anti-dumping and anti-subsidy cases, the U.S. has consistently taken into consideration the Chinese government's role in the market and the possible existence of subsidies, and has often placed relatively high anti-dumping taxes on Chinese businesses. However, in its anti-subsidy investigations, the U.S. has continued on to measure the amount of government subsidies to businesses, levying further anti-subsidy taxes. This actually means that the same issue is doubly taxed, which runs completely counter to the spirit of fair trade advocated within the WTO Subsidies and Countervailing Measures Agreement, and is doubly discriminatory against Chinese businesses.

The U.S. is implementing trade protectionism under the name of free trade; this is clearly the classic protectionist stratagem of abusing of trade relief measures.


  美对华反补贴已成为中美贸易摩擦的新焦点,美对华反补贴有违公平贸易规则的种种做法,已对中国企业正当的贸易利益构成伤害。5月25日中国商务部就美对华多起反补贴案中的错误做法,向 WTO提起诉讼。


  美对华反补贴的不公正性是导致双方冲突的焦点。美国不顾中国几十年市场经济改革的巨大成就,坚持视中国为非市场经济国家并开启对华反补贴。并且在反补贴调查中美国并不是根据中国政府对企业的真实补贴来确定补贴额,而是沿用反倾销调查中的替代国方法,即在中国以外寻找一个市场经济的外部基准作为中国市场“应该的价格”,并将中国国内价低于外部基准的差额确定为所谓的补贴。其实各国产品市场价存在差异是普遍存在的事实,这也是国际贸易与比较优势理论存在的基础。但对中国企业来说,这个差额却被美方无理地认定为补贴。美方在既无国际法依据,又有违美国国内法判例的情况下,实施对华反补贴,同时还通过替代国方法选择较高水平的外部基准,人为夸大中国产品的补贴幅度,导致事实上对中国企业不公正的裁决。


  美对华反补贴的另一不公正因素,也是此次中国申诉的核心,即“公共机构”的认定问题。美国带着中国政企不分的固有观念,无视中国国有企业在实行市场经济体制改革后,已脱离政府控制,独立经营、自负盈亏的事实,坚持认为只要政府在国企中拥有多数股权,这些国有企业的销售就有政府补贴。在许多个案中美在没有提供充分证据的情况下,认定国有企业是受政府控制的公共机构,这一做法此前已经被WTO上诉机构予以否定。尽管如此,美国还是继续坚持对公共机构扩大化解释的错误做法,结果导致了更多的中国出口产品受制于美国反补贴法,更多的中国企业赴美市场的努力几近归于无效。


  美对华反倾销反补贴的双重高额关税也广受诟病,因为其中包括了重复计税的问题。美国在双反案中的一贯做法是在反倾销判决中,考虑到中国政府在市场中的作用及可能存在的补贴,美国通常向中方企业征收较高的反倾销税。但同时在反补贴调查中,美国又进一步量化政府对企业的补贴并再征反补贴税,这事实上构成对同一情况双重计税,这与WTO补贴反补贴措施协议所倡导的公平贸易精神完全是背道而驰的,是对中国企业的双重歧视。


  美国以公平贸易之名行贸易保护之实,这无疑是典型的滥用贸易救济措施的保护主义的做法。
This post appeared on the front page as a direct link to the original article with the above link .

Hot this week

Topics

Poland: Meloni in the White House. Has Trump Forgotten Poland?*

Germany: US Companies in Tariff Crisis: Planning Impossible, Price Increases Necessary

Japan: US Administration Losing Credibility 3 Months into Policy of Threats

Mauritius: Could Trump Be Leading the World into Recession?

India: World in Flux: India Must See Bigger Trade Picture

Palestine: US vs. Ansarallah: Will Trump Launch a Ground War in Yemen for Israel?

Ukraine: Trump Faces Uneasy Choices on Russia’s War as His ‘Compromise Strategy’ Is Failing

Related Articles

Germany: US Companies in Tariff Crisis: Planning Impossible, Price Increases Necessary

Hong Kong: Can US Tariffs Targeting Hong Kong’s ‘Very Survival’ Really Choke the Life out of It?

Cuba: Trump, Panama and the Canal

China: White House Peddling Snake Oil as Medicine

China: Prime Take: How Do Americans View US Tariff Hikes?